Abstract
Brain glycogen is stored mainly in astrocytes, although neurons also have an active glycogen metabolism. Glycogen has gained relevance as a key player in brain function. In this regard, genetically modified animals have allowed researchers to unravel new roles of this polysaccharide in the brain. Remarkably, mice in which glycogen synthase is abolished in the brain, and thus devoid of brain glycogen, are viable, thereby indicating that the polysaccharide in this organ is not a requirement for survival. While there was growing evidence supporting a role of glycogen in learning and memory, these animals have now confirmed that glycogen participates in these two processes.
The association of epilepsy with brain glycogen has also attracted attention. Analysis of genetically modified mice indicates that the relation between brain glycogen and epilepsy is complex. While the formation of glycogen aggregates clearly underlies epilepsy, as in Lafora Disease (LD), the absence of glycogen also favors the occurrence of seizures.
LD is a rare genetic condition that affects children. It is characterized by epileptic seizures and neurodegeneration, and it develops rapidly until finally causing death. Research into this disease has unveiled new aspects of glycogen metabolism. Animal models of LD accumulate polyglucosan bodies formed by aberrant glycogen aggregates, called Lafora bodies (LBs). The abolition of glycogen synthase (GS) prevents the formation of LBs and the development of LD, thereby indicating that glycogen accumulation underlies this disease and the associated symptoms, and thus establishing a clear relation between the accumulation of glycogen aggregates and the incidence of seizures.
Although it was initially accepted that LBs were essentially neuronal, it is now evident that astrocytes also accumulate polyglucosan aggregates in LD. However, the appearance and composition of these deposits differs from that observed in neurons. Of note, the astrocytic aggregates in LD models show remarkable similarities with corpora amylacea (CA), a type of polyglucosan aggregate observed in the brains of aged mice and humans. The abolition of GS in mice also impedes the formation of CA with age and at the same time prevents the formation of a number of protein aggregates associated with aging. Therefore CA may play a role in age-related neurological decline.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsAbbreviations
- ANLS:
-
Astrocyte-neuron lactate shuttle
- APBD:
-
Adult polyglucosan body disease
- CAL:
-
Corpora amylacea-like
- DAB:
-
1,4-dideoxy-1,4-imino-d-arabinitol
- EPM2:
-
Progressive myoclonic epilepsy 2 GBE Glycogen branching enzyme
- GP:
-
Glycogen phosphorylase
- GS:
-
Glycogen synthase
- HFS:
-
High-frequency stimulus
- LBs:
-
Lafora bodies
- LD:
-
Lafora disease
- LFP:
-
Local field potential
- LGS:
-
Liver glycogen synthase
- LTP:
-
Long-term potentiation
- MGS:
-
Muscle glycogen synthase
- PGBs:
-
Polyglucosan bodies
- PP1:
-
Protein phosphatase 1
- PTG:
-
Protein targeting to glycogen
- SAMP8:
-
Senescence accelerated mouse prone 8
References
Alberini CM, Cruz E et al (2018) Astrocyte glycogen and lactate: new insights into learning and memory mechanisms. Glia 66(6):1244–1262
Auge E, Cabezon I et al (2017) New perspectives on corpora amylacea in the human brain. Sci Rep 7:41807
Auge E, Pelegri C et al (2018) Astrocytes and neurons produce distinct types of polyglucosan bodies in Lafora disease. Glia 66:2094–2107
Bernard-Helary K, Lapouble E et al (2000) Correlation between brain glycogen and convulsive state in mice submitted to methionine sulfoximine. Life Sci 67(14):1773–1781
Binder CJ (2010) Natural IgM antibodies against oxidation-specific epitopes. J Clin Immunol 30(Suppl 1):S56–S60
Bouskila M, Hunter RW et al (2010) Allosteric regulation of glycogen synthase controls glycogen synthesis in muscle. Cell Metab 12(5):456–466
Bruno C, Servidei S et al (1993) Glycogen branching enzyme deficiency in adult polyglucosan body disease. Ann Neurol 33(1):88–93
Cavanagh JB (1999) Corpora-amylacea and the family of polyglucosan diseases. Brain Res Brain Res Rev 29(2–3):265–295
Cisse S, Schipper HM (1995) Experimental induction of corpora amylacea-like inclusions in rat astroglia. Neuropathol Appl Neurobiol 21(5):423–431
Criado O, Aguado C et al (2012) Lafora bodies and neurological defects in Malin-deficient mice correlate with impaired autophagy. Hum Mol Genet 21(7):1521–1533
Dainese L, Monin ML et al (2013) Abnormal glycogen in astrocytes is sufficient to cause adult polyglucosan body disease. Gene 515(2):376–379
Dalsgaard MK, Madsen FF et al (2007) High glycogen levels in the hippocampus of patients with epilepsy. J Cereb Blood Flow Metab 27(6):1137–1141
Del Valle J, Duran-Vilaregut J et al (2010) Early amyloid accumulation in the hippocampus of SAMP8 mice. J Alzheimers Dis 19(4):1303–1315
Delgado-Escueta AV (2007) Advances in lafora progressive myoclonus epilepsy. Curr Neurol Neurosci Rep 7(5):428–433
DePaoli-Roach AA, Tagliabracci VS et al (2010) Genetic depletion of the malin E3 ubiquitin ligase in mice leads to lafora bodies and the accumulation of insoluble laforin. J Biol Chem 285(33):25372–25381
DiNuzzo M, Mangia S et al (2015) Does abnormal glycogen structure contribute to increased susceptibility to seizures in epilepsy? Metab Brain Dis 30(1):307–316
Duran J, Tevy MF et al (2012) Deleterious effects of neuronal accumulation of glycogen in flies and mice. EMBO Mol Med 4(8):719–729
Duran J, Saez I et al (2013) Impairment in long-term memory formation and learning-dependent synaptic plasticity in mice lacking glycogen synthase in the brain. J Cereb Blood Flow Metab 33(4):550–556
Duran J, Gruart A et al (2014) Glycogen accumulation underlies neurodegeneration and autophagy impairment in Lafora disease. Hum Mol Genet 23(12):3147–3156
Duran J, Gruart A et al (2019) Lack of Neuronal Glycogen Impairs Memory Formation and Learning-Dependent Synaptic Plasticity in Mice. Frontiers in Cellular Neuroscience 13
Ganesh S, Delgado-Escueta AV et al (2002) Targeted disruption of the Epm2a gene causes formation of Lafora inclusion bodies, neurodegeneration, ataxia, myoclonus epilepsy and impaired behavioral response in mice. Hum Mol Genet 11(11):1251–1262
Gayarre J, Duran-Trio L et al (2014) The phosphatase activity of laforin is dispensable to rescue Epm2a−/− mice from Lafora disease. Brain 137(Pt 3):806–818
Gentry MS, Dixon JE et al (2009) Lafora disease: insights into neurodegeneration from plant metabolism. Trends Biochem Sci 34(12):628–639
Gentry MS, Guinovart JJ et al (2018) Lafora disease offers a unique window into neuronal glycogen metabolism. J Biol Chem 293(19):7117–7125
Gibbs ME (2015) Role of Glycogenolysis in memory and learning: regulation by noradrenaline, Serotonin and ATP. Front Integr Neurosci 9:70
Gibbs ME, Anderson DG et al (2006) Inhibition of glycogenolysis in astrocytes interrupts memory consolidation in young chickens. Glia 54(3):214–222
Goldberg ND, O’Toole AG (1969) The properties of glycogen synthetase and regulation of glycogen biosynthesis in rat brain. J Biol Chem 244(11):3053–3061
Gruart A, Munoz MD et al (2006) Involvement of the CA3-CA1 synapse in the acquisition of associative learning in behaving mice. J Neurosci 26(4):1077–1087
Hertz L, Chen Y (2018) Glycogenolysis, an astrocyte-specific reaction, is essential for both astrocytic and neuronal activities involved in learning. Neuroscience 370:27–36
Hevor TK, Delorme P et al (1985) Glycogen content and fructose-1, 6-biphosphatase activity in methionine sulfoximine epileptogenic mouse brain and liver after protein synthesis inhibition. Neuropathol Appl Neurobiol 11(2):129–139
Jucker M, Walker LC et al (1994a) Age-related fibrillar deposits in brains of C57BL/6 mice. A review of localization, staining characteristics, and strain specificity. Mol Neurobiol 9(1–3):125–133
Jucker M, Walker LC et al (1994b) Age-related deposition of glia-associated fibrillar material in brains of C57BL/6 mice. Neuroscience 60(4):875–889
Kaslow HR, Lesikar DD et al (1985) L-type glycogen synthase. Tissue distribution and electrophoretic mobility. J Biol Chem 260(18):9953–9956
Knecht E, Criado-Garcia O et al (2012) Malin knockout mice support a primary role of autophagy in the pathogenesis of Lafora disease. Autophagy 8(4):701–703
Liu WJ, Ye L et al (2016) p62 links the autophagy pathway and the ubiqutin-proteasome system upon ubiquitinated protein degradation. Cell Mol Biol Lett 21:29
Lopez-Gonzalez I, Viana R et al (2017) Inflammation in Lafora disease: evolution with disease progression in Laforin and Malin Knock-out mouse models. Mol Neurobiol 54(5):3119–3130
Lopez-Ramos JC, Duran J et al (2015) Role of brain glycogen in the response to hypoxia and in susceptibility to epilepsy. Front Cell Neurosci 9:431
Lossos A, Meiner Z et al (1998) Adult polyglucosan body disease in Ashkenazi Jewish patients carrying the Tyr329Ser mutation in the glycogen-branching enzyme gene. Ann Neurol 44(6):867–872
Machado-Salas J, Avila-Costa MR et al (2012) Ontogeny of Lafora bodies and neurocytoskeleton changes in Laforin-deficient mice. Exp Neurol 236(1):131–140
Mancardi GL, Schenone A et al (1985) Polyglucosan bodies in the sural nerve of a diabetic patient with polyneuropathy. Acta Neuropathol 66(1):83–86
Manich G, Cabezon I et al (2016) Periodic acid-Schiff granules in the brain of aged mice: from amyloid aggregates to degenerative structures containing neo-epitopes. Ageing Res Rev 27:42–55
Martinez JL Jr, Derrick BE (1996) Long-term potentiation and learning. Annu Rev Psychol 47:173–203
Moore SA, Peterson RG et al (1981) Glycogen accumulation in tibial nerves of experimentally diabetic and aging control rats. J Neurol Sci 52(2–3):289–303
Nitschke F, Sullivan MA et al (2017) Abnormal glycogen chain length pattern, not hyperphosphorylation, is critical in Lafora disease. EMBO Mol Med 9(7):906–917
Nitschke F, Ahonen SJ et al (2018) Lafora disease - from pathogenesis to treatment strategies. Nat Rev Neurol 14(10):606–617
Oe Y, Baba O et al (2016) Glycogen distribution in the microwave-fixed mouse brain reveals heterogeneous astrocytic patterns. Glia 64(9):1532–1545
Orloff MJ, Greenleaf G et al (1990) Reversal of diabetic somatic neuropathy by whole-pancreas transplantation. Surgery 108(2):179–189; discussion 189–190
Osorio-Paz I, Sanchez-Chavez G et al (2012) Control of glycogen content in retina: allosteric regulation of glycogen synthase. PLoS One 7(2):e30822
Pederson BA, Turnbull J et al (2013) Inhibiting glycogen synthesis prevents lafora disease in a mouse model. In: Ann Neurol, vol 74, pp 297–300
Phelps CH (1975) An ultrastructural study of methionine sulphoximine-induced glycogen accumulation in astrocytes of the mouse cerebral cortex. J Neurocytol 4(4):479–490
Pirici I, Margaritescu C et al (2014) Corpora amylacea in the brain form highly branched three-dimensional lattices. Romanian J Morphol Embryol 55(3 Suppl):1071–1077
Powell H, Knox D et al (1977) Alloxan diabetic neuropathy: electron microscopic studies. Neurology 27(1):60–66
Raben N, Danon M et al (2001) Surprises of genetic engineering: a possible model of polyglucosan body disease. Neurology 56(12):1739–1745
Roach PJ, Cheng C et al (1998) Novel aspects of the regulation of glycogen storage. J Basic Clin Physiol Pharmacol 9(2–4):139–151
Rohn TT (2015) Corpora amylacea in neurodegenerative diseases: cause or effect? Int J Neurol Neurother 2(3):031
Rubio-Villena C, Viana R et al (2018) Astrocytes: new players in progressive myoclonus epilepsy of Lafora type. Hum Mol Genet 27(7):1290–1300
Rungger-Brandle E, Kolb H et al (1996) Histochemical demonstration of glycogen in neurons of the cat retina. Invest Ophthalmol Vis Sci 37(5):702–715
Saez I, Duran J et al (2014) Neurons have an active glycogen metabolism that contributes to tolerance to hypoxia. J Cereb Blood Flow Metab 34:945–955
Sanchez-Chavez G, Hernandez-Berrones J et al (2008) Effect of diabetes on glycogen metabolism in rat retina. Neurochem Res 33(7):1301–1308
Simo R, Hernandez C et al (2014) Neurodegeneration in the diabetic eye: new insights and therapeutic perspectives. Trends Endocrinol Metab 25(1):23–33
Sinadinos C, Valles-Ortega J et al (2014) Neuronal glycogen synthesis contributes to physiological aging. Aging Cell 13(5):935–945
Singhrao SK, Neal JW et al (1993) Corpora amylacea could be an indicator of neurodegeneration. Neuropathol Appl Neurobiol 19(3):269–276
Sosula L, Beaumont P et al (1974) Glycogen accumulation in retinal neurons and glial cells of streptozotocin-diabetic rats. Quantitative electron microscopy. Diabetes 23(3):221–231
Takeda T (2009) Senescence-accelerated mouse (SAM) with special references to neurodegeneration models, SAMP8 and SAMP10 mice. Neurochem Res 34(4):639–659
Turnbull J, DePaoli-Roach AA et al (2011) PTG depletion removes Lafora bodies and rescues the fatal epilepsy of Lafora disease. PLoS Genet 7(4):e1002037
Valles-Ortega J, Duran J et al (2011) Neurodegeneration and functional impairments associated with glycogen synthase accumulation in a mouse model of Lafora disease. EMBO Mol Med 3(11):667–681
Vilchez D, Ros S et al (2007) Mechanism suppressing glycogen synthesis in neurons and its demise in progressive myoclonus epilepsy. Nat Neurosci 10(11):1407–1413
Vincent AM, Feldman EL (2004) New insights into the mechanisms of diabetic neuropathy. Rev Endocr Metab Disord 5(3):227–236
Waitt AE, Reed L et al (2017) Emerging roles for glycogen in the CNS. Front Mol Neurosci 10:73
Walls AB, Eyjolfsson EM et al (2014) A subconvulsive dose of kainate selectively compromises astrocytic metabolism in the mouse brain in vivo. J Cereb Blood Flow Metab 34(8):1340–1346
von Wilamowitz-Moellendorff A, Hunter RW et al (2013) Glucose-6-phosphate-mediated activation of liver glycogen synthase plays a key role in hepatic glycogen synthesis. Diabetes 62(12):4070–4082
Wilhelmus MM, Verhaar R et al (2011) Novel role of transglutaminase 1 in corpora amylacea formation? Neurobiol Aging 32(5):845–856
Yagihashi S, Matsunaga M (1979) Ultrastructural pathology of peripheral nerves in patients with diabetic neuropathy. Tohoku J Exp Med 129(4):357–366
Zotova EG, Schaumburg HH et al (2008) Effects of hyperglycemia on rat cavernous nerve axons: a functional and ultrastructural study. Exp Neurol 213(2):439–447
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Duran, J., Gruart, A., López-Ramos, J.C., Delgado-García, J.M., Guinovart, J.J. (2019). Glycogen in Astrocytes and Neurons: Physiological and Pathological Aspects. In: DiNuzzo, M., Schousboe, A. (eds) Brain Glycogen Metabolism. Advances in Neurobiology, vol 23. Springer, Cham. https://doi.org/10.1007/978-3-030-27480-1_10
Download citation
DOI: https://doi.org/10.1007/978-3-030-27480-1_10
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-27479-5
Online ISBN: 978-3-030-27480-1
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)